Joincare Pharmaceutical Group Industry Co.,Ltd. (SHA:600380)
China · Delayed Price · Currency is CNY 10.88
0.00 (0.00%)
Apr 28, 2026, 3:00 PM CST
SHA:600380 Revenue
Joincare Pharmaceutical Group Industry had revenue of 3.72B CNY in the quarter ending March 31, 2026, a decrease of -8.99%. This brings the company's revenue in the last twelve months to 14.85B, down -3.39% year-over-year. In the year 2025, Joincare Pharmaceutical Group Industry had annual revenue of 15.22B, down -2.58%.
Revenue (ttm)
14.85B
Revenue Growth
-3.39%
P/S Ratio
1.31
Revenue / Employee
1.03M
Employees
14,350
Market Cap
19.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15.22B | -403.74M | -2.58% |
| Dec 31, 2024 | 15.62B | -1.03B | -6.17% |
| Dec 31, 2023 | 16.65B | -496.40M | -2.90% |
| Dec 31, 2022 | 17.14B | 1.24B | 7.79% |
| Dec 31, 2021 | 15.90B | 2.38B | 17.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Resources Double-Crane Pharmaceutical | 10.73B |
| Apeloa Pharmaceutical Co.,Ltd | 9.50B |
| Betta Pharmaceuticals | 3.73B |
| Tonghua Dongbao Pharmaceutical | 2.95B |
| Walvax Biotechnology | 2.40B |
| Jilin Aodong Pharmaceutical Group | 2.34B |
| Wedge Industrial | 1.32B |
| Wanbangde Pharmaceutical Holding Group | 1.14B |